Key Record Dates Identifier: NCT04497844
Brief Title: A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) (AMPLITUDE)

First Submitted : July 31, 2020
First Submitted that Met QC Criteria : July 31, 2020
First Posted : August 4, 2020

Last Update Submitted that Met QC Criteria : May 27, 2021
Last Update Posted : May 28, 2021